Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma
- PMID: 11337516
Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma
Abstract
There are several reports about the usefulness of (18)F-FDG PET in thyroid cancer. However, few studies have compared FDG PET with (131)I and (201)Tl scintigraphy. The aim of this study was to evaluate the clinical significance of whole-body FDG PET in differentiated thyroid cancer and to compare the results with those obtained from (131)I and (201)Tl scintigraphy.
Methods: Whole-body FDG PET was performed on 32 patients (10 men, 22 women; age range, 30-77 y; mean age, 54 y) with differentiated thyroid cancer (5 cases of follicular cancer and 27 of papillary cancer) after total thyroidectomy. An overall clinical evaluation was performed, including cytology, thyroglobulin level, sonography, MRI, and CT, to allow a comparison with functional imaging results for each patient. Metastatic regions were divided into five areas: neck, lung, mediastinum, bone, and other. Multiple lesions in one area were defined as one lesion. The tumor-to-background ratio (TBR) was measured for the lesions that were positive for both (201)Tl uptake and FDG PET uptake.
Results: The number of lesions totaled 47. Forty-one (87%) were detected by all scintigraphic methods. FDG uptake was concordant with (131)I uptake in only 18 lesions (38%). FDG uptake was concordant with (201)Tl uptake in 44 lesions (94%). Only one lesion was negative for FDG uptake and positive for (201)Tl uptake, and two lesions were positive for FDG uptake and negative for (201)Tl uptake. A significant correlation was seen between the TBR of (201)Tl and that of FDG (r = 0.69; P<0.05).
Conclusion: These data indicate that for detecting metastatic lesions, FDG PET and (131)I scintigraphy may provide complementary information, whereas FDG PET may provide results similar to those of (201)Tl scintigraphy. Thus, the combination of (131)I scintigraphy and FDG PET (or (201)Tl scintigraphy) is the method of choice for detecting metastatic thyroid cancer after total thyroidectomy.
Similar articles
-
Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.Semin Nucl Med. 2006 Jul;36(3):194-205. doi: 10.1053/j.semnuclmed.2006.03.002. Semin Nucl Med. 2006. PMID: 16762610 Review.
-
Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.Eur J Nucl Med Mol Imaging. 2004 Apr;31(4):491-8. doi: 10.1007/s00259-003-1403-y. Epub 2003 Dec 10. Eur J Nucl Med Mol Imaging. 2004. PMID: 14666387 Clinical Trial.
-
Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.Eur J Nucl Med. 2001 May;28(5):639-45. Eur J Nucl Med. 2001. PMID: 11383871
-
Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.J Nucl Med. 1999 Jun;40(6):986-92. J Nucl Med. 1999. PMID: 10452315
-
Positron emission imaging of head and neck cancer, including thyroid carcinoma.Semin Nucl Med. 2004 Jul;34(3):180-97. doi: 10.1053/j.semnuclmed.2004.03.004. Semin Nucl Med. 2004. PMID: 15202100 Review.
Cited by
-
2-Deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and positron emission tomography/computed tomography diagnosis of patients with recurrent papillary thyroid cancer.Mol Imaging Biol. 2006 Sep-Oct;8(5):309-14. doi: 10.1007/s11307-006-0046-3. Mol Imaging Biol. 2006. PMID: 16758370
-
The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer.AJNR Am J Neuroradiol. 2009 Aug;30(7):1431-4. doi: 10.3174/ajnr.A1559. Epub 2009 Apr 2. AJNR Am J Neuroradiol. 2009. PMID: 19342543 Free PMC article.
-
Lung uptake on I-131 therapy and short-term outcome in patients with lung metastasis from differentiated thyroid cancer.Ann Nucl Med. 2014 Feb;28(2):81-7. doi: 10.1007/s12149-013-0781-x. Epub 2013 Dec 28. Ann Nucl Med. 2014. PMID: 24374647 Free PMC article.
-
Treatment Response following Radioactive Iodine Therapy in Miliary versus Macronodular Pulmonary Metastases in Papillary Thyroid Carcinoma.World J Nucl Med. 2022 Apr 30;21(1):52-58. doi: 10.1055/s-0042-1746175. eCollection 2022 Mar. World J Nucl Med. 2022. PMID: 35502279 Free PMC article.
-
Clinical Perspectives of Theranostics.Molecules. 2021 Apr 13;26(8):2232. doi: 10.3390/molecules26082232. Molecules. 2021. PMID: 33924345 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical